Patients should not stop taking prescribed medication without first consulting a healthcare provider, as abrupt changes can pose additional risks
The drug, sold under the brand name Wegovy, cut patients risk of major cardiovascular problems by 20 percent, Lincoff reported November 11
The starting dose used in phase 2 clinical trials has been low, with a gradual, pre-specified dose-escalation schedule over subsequent weeks to improve tolerability
Unboxed: 7 natural products for GLP-1 support Discover the new class of natural supplements and foods that are helping consumers manage weight and appetite, as well as the side effects of using semaglutides, known as GLP-1
The ability to export reports and share data with your doctor changes tracking from just personal record-keeping into useful medical discussions
Health insurers are not racing to cover the roughly US$1,000-a-month (S$1,300) brand-name drugs, leading people to seek cheaper alternatives elsewhere